Burzynski Research Institute, Inc. (OTCPK: BZYR)
Health Care · Biotechnology · US
$0.00
-89.74% today · -99.6% 1Y
Burzynski Research Institute, Inc. (OTCPK: BZYR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $26.29K and employs 1 people.
Over the last twelve months the share price has lost 99.6%, trading between 0.00 and 0.05.
Tweenvest scores Burzynski Research Institute, Inc. across four factors: quality 17/100, value 41/100. Its strongest factor is value.
BZYR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $26.29K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- $0.05
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 131.45M
- Employees
- 1
- Next earnings
- —
About Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
- ISIN
- US1231591058
- Founded
- 1977
- Listed since
- Jan 2, 1997
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Plandaí Biotechnology, Inc.OTCPK: PLPL | $44.89K | $0.00 | -99.00% |
| Emergent Health CorpOTCPK: EMGE | $42.70K | $0.00 | — |
| Nascent Biotech, Inc.OTCPK: NBIO | $34.57K | $0.00 | +100.00% |
| Myrexis, Inc.OTCPK: MYRX | $27.58K | $0.00 | — |
| Biostax Corp.OTCPK: BTAX | $21.65K | $— | — |
| Carisma Therapeutics, Inc.OTCPK: CARM | $20.92K | $0.00 | -37.50% |
| Dragon Life Science Holdings Group, Inc.OTCPK: NOHO | $20.04K | $0.00 | — |
| T2 Biosystems, Inc.OTCPK: TTOO | $19.63K | $0.00 | +16.67% |
Figures last refreshed Oct 18, 2026.